Most lately, it's been determined that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds into a big selection of endogenous opioids. Contrary to most opioid receptors, this receptor functions as a scavenger https://ashleighg007ftb9.prublogger.com/profile